A carregar...

Methodological Aspects of the Phase II Study AFF006 Evaluating Amyloid-beta -Targeting Vaccine AFFITOPE® AD02 in Early Alzheimer’s Disease – Prospective Use of Novel Composite Scales

BACKGROUND: Optimized scales and composite outcomes have been proposed as a way to more accurately measure Alzheimer’s disease related decline. AFFITOPE® AD02, is an amyloid-beta (Aβ)-targeting vaccine to elicit anti-Aβ antibodies. IMM-AD04, commonly known as Alum, originally designated as a control...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Prev Alzheimers Dis
Main Authors: Hendrix, S., Ellison, N., Stanworth, S., Tierney, L., Mattner, F., Schmidt, W., Dubois, B., Schneeberger, A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746013/
https://ncbi.nlm.nih.gov/pubmed/26866015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14283/jpad.2015.67
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!